These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. With your genes? Take one of these, three times a day. Abbott A Nature; 2003 Oct; 425(6960):760-2. PubMed ID: 14574377 [No Abstract] [Full Text] [Related]
3. Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics. Nebert DW; Vesell ES Trends Pharmacol Sci; 2006 Nov; 27(11):580-6. PubMed ID: 17005258 [TBL] [Abstract][Full Text] [Related]
5. The possible clinical application of pharmacogenetics in rheumatology. Ferraccioli G J Rheumatol; 2003 Dec; 30(12):2517-20. PubMed ID: 14719186 [No Abstract] [Full Text] [Related]
7. Advances in the pharmacogenomics of adverse drug reactions. Alvarado I; Wong ML; Licinio J Pharmacogenomics J; 2002; 2(5):273. PubMed ID: 12439730 [No Abstract] [Full Text] [Related]
8. SNPs--where's the beef? Roses AD Pharmacogenomics J; 2002; 2(5):277-83. PubMed ID: 12439733 [No Abstract] [Full Text] [Related]
9. Pharmacogenetics in the laboratory and the clinic. Goldstein DB N Engl J Med; 2003 Feb; 348(6):553-6. PubMed ID: 12571264 [No Abstract] [Full Text] [Related]
10. Efforts in pharmacogenetics will help patients get right amount of right drug. Dunn MJ WMJ; 2008 Apr; 107(2):103-4. PubMed ID: 18593086 [No Abstract] [Full Text] [Related]
11. [Pharmacogenomics: way to individual therapy]. Piruzian AL Eksp Klin Farmakol; 2005; 68(5):59-67. PubMed ID: 16277215 [TBL] [Abstract][Full Text] [Related]
12. [Preventable or unavoidable? A new stage in the topic of drug safety]. Otero MJ; Bajo A; García-Gutiérrez JF; Domínquez-Gil A Med Clin (Barc); 1999 Mar; 112(10):398-9. PubMed ID: 10227024 [No Abstract] [Full Text] [Related]
14. Genotypic Approaches to Therapy in Children (GATC): using information technology to improve drug safety. Wong E; Carleton BC; Wright DF; Smith MA; Verbeek L; Hildebrand CA; Stannard P; Vaillancourt R; Elliot-Miller P; Ross CJ; Hayden MR Stud Health Technol Inform; 2009; 143():209-14. PubMed ID: 19380938 [TBL] [Abstract][Full Text] [Related]
15. Ready when you are: easing into preemptive pharmacogenetics. He YJ; McLeod HL Clin Pharmacol Ther; 2012 Oct; 92(4):412-4. PubMed ID: 22992667 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenomics for adverse drug reactions]. Saito Y; Sai K; Sawada J Nihon Rinsho; 2010 Aug; 68 Suppl 8():263-8. PubMed ID: 20979280 [No Abstract] [Full Text] [Related]
18. Pharmacogenomic discovery approaches: will the real genes please stand up? Walgren RA; Meucci MA; McLeod HL J Clin Oncol; 2005 Oct; 23(29):7342-9. PubMed ID: 16145062 [TBL] [Abstract][Full Text] [Related]
19. Editorial: SNPs of drug metabolic enzymes and personalized medicine Part II. Wei DQ; Chen Q Curr Drug Metab; 2012 Sep; 13(7):951. PubMed ID: 22475268 [No Abstract] [Full Text] [Related]
20. Perspectives on epigenetics and its relevance to adverse drug reactions. Kacevska M; Ivanov M; Ingelman-Sundberg M Clin Pharmacol Ther; 2011 Jun; 89(6):902-7. PubMed ID: 21508940 [No Abstract] [Full Text] [Related] [Next] [New Search]